Vertex Pharmaceuticals Inc. buy Barclays PLC
Start price
06.02.24
/
50%
€387.70
Target price
06.02.25
€439.24
Performance (%)
2.81%
Price
13.05.24
€398.60
Summary
This prediction is currently active. The BUY prediction by Barclays_PLC shows slight gains of 2.81%. This prediction currently runs until 06.02.25. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Vertex Pharmaceuticals Inc. | 5.368% | 5.368% |
iShares Core DAX® | 4.094% | 4.888% |
iShares Nasdaq 100 | 1.424% | -0.445% |
iShares Nikkei 225® | -1.572% | -4.911% |
iShares S&P 500 | 1.822% | 0.776% |
Comments by Barclays_PLC for this prediction
In the thread Vertex Pharmaceuticals Inc. diskutieren
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) had its price target raised by analysts at Barclays PLC from $446.00 to $472.00. They now have an "overweight" rating on the stock.
Ratings data for VRTX provided by MarketBeat
Stopped prediction by Barclays_PLC for Vertex Pharmaceuticals Inc.
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€327.60
11.12.23
11.12.23
€385.41
11.12.24
11.12.24
21.67%
13.05.24
13.05.24